Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluated rituximab with fludarabine and cyclophosphamide as initial therapy for elderly patients with chronic lymphocytic leukemia; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2018-04-23